MedPath
FDA Approval

Itraconazole Oral

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Natco Pharma USA LLC
DUNS: 079590418
Effective Date
August 5, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Itraconazole(10 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Annora Pharma Private Limited

Natco Pharma USA LLC

650980746

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Itraconazole Oral

Product Details

NDC Product Code
69339-159
Application Number
ANDA212239
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
April 11, 2022
ascorbic acidInactive
Code: PQ6CK8PD0RClass: IACT
propylene glycolInactive
Code: 6DC9Q167V3Class: IACT
hydrochloric acidInactive
Code: QTT17582CBClass: IACT
Code: 304NUG5GF4Class: ACTIBQuantity: 10 mg in 1 mL
waterInactive
Code: 059QF0KO0RClass: IACT
noncrystallizing sorbitol solutionInactive
Code: 9E0S3UM200Class: IACT
saccharin sodiumInactive
Code: SB8ZUX40TYClass: IACT
sodium hydroxideInactive
Code: 55X04QC32IClass: IACT
© Copyright 2025. All Rights Reserved by MedPath